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Background: Pediatric health-related quality of life (HRQL) measures explore multiple domains of HRQL. To ease
administration, burden, and implementation, we created a 7-item unidimensional global HRQL scale for children.
This paper evaluates the psychometric properties of the global HRQL scale in children undergoing hematopoietic
stem cell transplant (HSCT) and describes the trajectory of global HRQL scores over the 12-month course following
HSCT.
Methods: As part of two longitudinal HSCT studies, HRQL was collected on 312 parent–child dyads using the Child
Health Ratings Inventories. Parents of children aged 5–18 completed the pediatric global HRQL scale about their
child and 117 adolescents completed the scale themselves. Psychometric properties were compared across both
raters. Two repeated measures models were built to describe trajectories of (1) global HRQL for all children based
on parent proxy report and (2) global HRQL for adolescents based on adolescent self-report and parent proxy
report.
Results: Internal consistency reliability was high for parent proxy report and adolescent self-report (Cronbach’s
alpha 0.9, 0.8, respectively). Unidimensionality was verified using principal components analysis. Both models
indicated decreased global HRQL in the presence of early complications related to HSCT and Model 1 further
indicated decreased HRQL in the presence of later complications. Model 2 showed that parent proxies reported
lower global HRQL scores than adolescent self-report.
Conclusions: This study has demonstrated the unidimensionality and strong psychometric properties of a 7-item
global HRQL scale in a sample of children undergoing HSCT. Despite its brevity, scale scores vary in clinically
meaningful ways. Future applications of this scale are encouraged.
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reproduction in any medium, provided the oroutcomes [1]. Due to methodological considerations (e.g.,
cognitive development), the field of HRQL measure-
ment in children and adolescents initially lagged behind
the development and validation of generic and disease-
specific HRQL measures for adults [2]. Over the past
two decades, this gap has been closing; there are
currently several generic and disease-specific HRQL
measures for children and adolescents that use self-
report and/or parent proxy report [3-9].
Nearly all of the health profile HRQL measures for
adults and children contain multiple domains for meas-
uring the multidimensional constructs of HRQL, suchl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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functioning, and role functioning [3-10]. Some measures,
such as the PedsQL™ 4.0, produce a total score, while other
measures report domain-specific scores or subscale scores.
Only recently has a unidimensional domain of global
HRQL for adults been developed as part of the Patient-
Reported Outcome Measurement Information System
(PROMIS) project [11], a US National Institutes of Health
(NIH)-funded initiative that develops and validates do-
mains to measure feelings, functions, and perceptions ap-
plicable to a range of chronic conditions (www.nihpromis.
org). To date, there is currently no comparable global
HRQL scale for use in pediatric populations.
Global HRQL scales have appeal over other multidimen-
sional HRQL measures for several reasons: (1) decreased
respondent burden, (2) increased ease of implementation,
(3) increased simplicity associated with having a single
HRQL score, and (4) potential to direct future research
and evaluation. With decreased respondent burden and
increased ease of implementation, global HRQL scales
could be used in a larger number of research studies
and could also be used more frequently in longitudinal
studies as compared to longer, multidimensional HRQL
measures. Rather than having several different HRQL
domain scores, the simplicity of having a single global
HRQL score also could result in increased use in
research studies and could eventually lead to use in
clinical practice. Finally, the global HRQL scale could
serve as a screener for further evaluation. For example,
those who score at the lower extreme of the scale may
receive additional questions to further understand why
their global HRQL is low, or they could be targeted for
intervention.
The first aim of this paper is to assess the psychomet-
ric properties of a pediatric global HRQL scale from the
Child Health Ratings Inventories (CHRIs) in a sample of
children prior to undergoing hematopoietic stem cell
transplant (HSCT). The second aim is to determine the
trajectory of the global HRQL scale scores over a 12-
month period among two subgroups: (1) “all children”
based on parent proxy report and (2) “adolescents only”
based on adolescent self-report and parent proxy report.
We rely on a sample of 312 children undergoing HSCT
and their parents, which offers a unique opportunity to
assess the performance of this global HRQL scale and
the trajectories over time during an intense clinical
course that is expected to result in changing HRQL.
Methods
Participants
This analysis draws on two completed studies: (1) 165
pediatric HSCT recipients aged 5–18 and their parents
who were both enrolled in the Journeys to Recovery
(JTR) study, which described the 12-month HRQLtrajectory following HSCT and (2) 198 pediatric HSCT
recipients aged 0–18 years and their parents who were
both enrolled in the HSCT-Comprehensive Health En-
hancement Support Study (CHESS™), which was a ran-
domized controlled trial of a web-based intervention
designed to improve the health-related knowledge, skills,
and quality of life of parents of children undergoing
HSCT. Together, these studies were conducted at eight
HSCT centers across the United States from 2003 to
2011. Eligibility included a working knowledge of
English and having a parent/legal guardian who could
consent on behalf of the child. Parental consent and age-
appropriate assent were obtained. Both studies were
approved by the institutional review board (IRB) at Tufts
Medical Center and at each clinical site; IRB approval
was also obtained to combine data from these studies.
Because the HRQL measures used to create the outcome
for this analysis were developed for use in children and
adolescents aged 5–18, parent and child dyads were re-
moved from the analysis if the child was less than five
years old, resulting in a final sample size of 312.Measures
Child Health Ratings Inventories (CHRIs)
This validated measure has been used extensively in
pediatric HSCT populations [4,5]. The parental version of
the CHRIs-General module includes two principal sec-
tions. The first section elicits parental ratings of the child’s
health and functioning, while the second section elicits
the parent’s rating of his/her own functioning. The school-
aged child version (ages 5–12) of the CHRIs-General
module elicits the child’s rating of their own health and
functioning using pictorial response sets, while the ado-
lescent version (ages 13–18) is text-based with parallel
wording to the parent version. Items from each of these
versions form three domains of generic HRQL: physical,
role, and emotional functioning. In addition to these
three domains of HRQL, the CHRIs-General parent and
adolescent versions also include an overview section
that asks seven items relating to the child’s global HRQL
(see Table 1 for item content), and is the focus of this
paper. Unlike the items that form the three domains of
HRQL, school-aged children do not complete questions
about their personal appraisal of overall health and
HRQL due to developmental reasons. All CHRIs items
use an acute, 1-week recall period because of the rapidly
changing health status of pediatric patients undergoing
transplant. All response sets have five options. Using the
half scale rule, which requires that at least half the items
in a scale be completed, the seven items were averaged
together to create a summary score, and then transformed
to a 100-point scale. Positive HRQL was coded as closer
to 100.
Table 1 Global HRQL items for parent proxy reporta
Question Response Option
During the past week, how would you rate the





a. Physical health Fair






a Wording for the adolescent self-report items replaces the phrase “your
child’s” with “your”.
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As part of the baseline assessment in both studies,
demographic variables on the patients and their parents
were obtained using the parent demographic form of
the CHRIs. Trained research staff collected clinical data
from medical records, including the following baseline
variables: transplant type (autologous, related allogen-
eic, unrelated allogeneic), causal diagnosis (malignancy
vs. non-malignancy), and duration of illness in months.
The natural logarithm of duration of illness was used
because it was highly skewed.
Data on clinical outcomes were also obtained from the
medical chart at the end of transplant hospitalization and
at each follow-up time by trained research staff. Acute
graft versus host disease (aGVHD) and transplant toxicity
(as measured by the Bearman toxicity scale) [12] were col-
lected at the end of hospitalization, 45 days, and 3 months.
Chronic graft versus host disease (cGVHD) was collected
at the end of hospitalization, 3, 6, and 12 months. Infec-
tion within the previous week was collected at all time
points, using the Common Toxicity Criteria of Adverse
Events, v. 3.0. A dichotomous composite variable was cre-
ated to indicate complications during the first 3 months
post-HSCT (hereafter “early complications”). Early com-
plications was defined as experiencing at least one of the
following: aGVHD of grade 2 or higher, intermediate or
poor toxicity (indicating intermediate or high levels of
toxicity), or localized or systemic infection. A separate
dichotomous variable was created to indicate the presence
of limited or extensive cGVHD between month 6 and 12.Statistical analysis
Demographic and clinical variables were summarized
separately for parents of all children aged 5–18 and ado-
lescents aged 13–18 using means (standard deviations
(SD)) or medians (25th-75th percentiles) for continuousvariables or using frequencies and percentages for cat-
egorical variables.
Scale construction and psychometric properties at baseline
Scale construction and psychometric analyses used base-
line data separated into three groups: (1) parent proxy
report for all children (aged 5–18), (2) parent proxy report
for adolescents (aged 13–18), and (3) adolescent self-
report. Principal components analysis was used to deter-
mine if the global HRQL scale was unidimensional. We
examined scree plots to identify the number of principal
components, as indicated by eigenvalues of at least 1.00,
and then estimated factor solutions. When identifying
principal components, each item should have a factor
loading ≥ .40. The amount of variation explained by the
component(s) selected was also reported. Cronbach’s
alpha was calculated to estimate the internal consistency
reliability of the global HRQL scale [13]. The minimum
acceptable criterion for Cronbach’s alpha in exploratory
scale development is .70, whereas for established scales,
Cronbach’s alpha should exceed .80 [14]. Means, SDs,
ceiling and floor effects, and percent missing were calcu-
lated for each item and the global HRQL scale score.
Repeated measures model to explore global HRQL
trajectory over time
In addition to exploring global HRQL trajectories, these
models also allow us to begin establishing the construct
validity of the scale. Two separate repeated measures
models were constructed: (1) global HRQL for all children
based on parent proxy report (“all children” model) and
(2) global HRQL for adolescents based on adolescent self-
report and parent proxy report (“adolescent only” model).
The outcome variable was the global HRQL score, as
measured by the CHRIs, at baseline, 45 days, and 3, 6, and
12 months. Given the non-linear relationship between
time and the outcome, time was treated as a categorical
variable with baseline as the reference. We used max-
imum likelihood estimation with repeated measures in
SAS Proc Mixed to account for the correlations over time,
with an unstructured covariance matrix. Univariate ana-
lysis was done to determine which variables to potentially
include in the multivariable models and variables with
p > 0.1 were then removed using backwards elimination.
For the “all children” model, the following variables and
interaction terms were considered: baseline parental emo-
tional functioning, child age, parent gender, child gender,
baseline timing, log duration of illness, transplant type,
early complications, late cGVHD, time interacted with
(hereafter noted by *) baseline parental emotional func-
tioning, time*baseline timing, time*early complications,
and time*late cGVHD. In addition to the variables in the
“all children” model, the “adolescent only” model also
considered an indicator for rater (parent or child),
Table 2 Baseline demographic and clinical characteristics
for parent proxy report and adolescent self-report
Mean (SD), n (%), or median
(25th to 75th percentile)
Parent proxy report, n=312
Parent age, mean (SD) 39.8 (7.1)
Parent female, n (%) 261 (83.7%)
Baseline parental emotional functioning,
mean (SD)
49.9 (19.2)
Child age, mean (SD) 10.9 (4.2)
Child female, n (%) 158 (50.6%)
Transplant Type
Autologous 70 (22.4%)
Allogeneic, related 84 (26.9%)
Allogeneic, unrelated 158 (50.6%)
Causal Malignancy, n (%) 236 (75.6%)










Child age, mean (SD) 15.6 (1.8)
Child female, n (%) 54 (46.2%)
Transplant Type, n (%)
Autologous 28 (23.9%)
Allogeneic, related 31 (26.5%)
Allogeneic, unrelated 58 (49.6%)
Causal Malignancy, n (%) 96 (82.1%)






Baseline measures during preparative
regimen, n (%)
39 (33.3%)
Abbreviations: SD standard deviation, JTR Journeys to Recovery, HSCT-CHESS™
Hematopoietic Stem Cell Transplant-Comprehensive Health Enhancement
Support Study (CHESS™).
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parent gender*rater, and child age*rater. Baseline parental
emotional functioning was included because it has been
shown to be associated with the child’s HRQL [15,16].
Linear and quadratic forms of child age were tested. Base-
line timing was an indicator for whether or not the base-
line HRQL assessment was completed before or during
the child’s preparative regimen; our previous research
shows that those completing assessments during the pre-
parative regimen reported lower HRQL scores [17]. We
chose to build a separate model for adolescents because
self-ratings were not available in younger children.
To address the possibility that outcome data may have
been missing not at random (MNAR), we stratified the
analysis by the extent of missing data, defining strata as
follows: (1) those with any missing data due to medical
reasons and (2) those with complete data or those with
missing data due to non-medical reasons. The stratified
models (called pattern mixture models (PMM)) [18]
assume the data are missing at random (MAR) within
strata. We compared stratified to unstratified models
using likelihood ratio tests (LRT).
All analyses were done in SAS version 9.2 (SAS Institute,
Inc. Cary, NC, USA); the alpha-level was set at 0.05.
Results
There were 312 parent proxy reports and 117 adolescent
self reports (see Table 2). Parents had a mean age of 40
(SD=7) and were predominately mothers (84%). Children
and adolescents combined had a mean age of 11 (SD=4)
and were 51% female. Unrelated allogeneic transplant
was the most common transplant type (51%) and 76% of
children and adolescents had a malignancy as their
causal diagnosis. Over the 12-month HSCT course, 34%
of children and adolescents had early complications,
while 4% had late cGVHD.
Scale construction and psychometric properties at
baseline
Principal components analysis indicated that the global
HRQL scale was unidimensional for all three groups: (1) all
children parent proxy report, (2) adolescent only parent
proxy report, and (3) adolescent self-report. The scree plots
for each of the three different groups indicated only one
component with an eigenvalue greater than 1.0 and all
factor loadings exceeded .40. The amount of variation
explained by the single component was 62% for parent
proxy report of all children, 64% for parent proxy report of
adolescent, and 45% for adolescent self-report. Cronbach’s
alpha was .90 for parent proxy report of all children, .91 for
parent proxy report of adolescents, and .80 for adolescent
self-report. Item- and scale-level psychometrics are
presented in Table 3. Of note, the physical health item had
the lowest mean score of all the items. Variability wassimilar across items and between raters and there was no
indication of strong ceiling or floor effects. There was very
little missing data for each item (< 2%).
Repeated measures model to explore global HRQL
trajectory over time
All children model results
The following covariates and interaction terms were
significant in univariate analysis and were not removed
Table 3 Baseline item and scale psychometrics
All Children (5–18 years) Adolescents Only (13–18 years)





























54.0 (26.7) 5.2 11.3 0.6 50.6 (26.3) 5.2 9.5 0.9 58.2 (27.1) 6.0 15.5 0.9
Mental health 60.6 (28.4) 2.9 20.9 0.3 57.5 (28.9) 4.3 18.0 0.0 69.6 (25.7) 1.7 29.3 0.9
Family life 65.8 (27.2) 1.9 25.4 0.3 64.7 (26.3) 1.7 23.1 0.0 75.0 (24.3) 0.0 38.3 1.7
Friendships 60.0 (30.5) 8.4 21.9 0.6 60.5 (30.5) 8.6 23.1 0.0 73.9 (29.1) 4.4 44.4 1.7
Self-
confidence
67.4 (25.1) 1.3 23.5 0.3 66.2 (25.5) 1.7 21.4 0.0 72.0 (24.3) 1.7 31.0 0.9
Fun 60.0 (28.8) 7.1 19.0 0.3 57.3 (27.9) 6.0 15.4 0.0 68.5 (29.4) 6.1 33.9 1.7
Life
Enjoyment
60.4 (28.2) 3.9 19.6 0.3 55.6 (26.9) 5.1 11.1 0.0 66.4 (27.6) 6.0 25.0 0.9
Abbreviations: SD standard deviation.
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wards elimination: time, baseline parental emotional
functioning, child age, baseline timing, log duration
of illness, transplant type, early complications, late
cGVHD, time*baseline timing, time*early complica-
tions, and time*late complications. The LRT comparing
the repeated measures model to the PMM revealed the
presence of MNAR by medical missingness (χ2 [df = 25] =
168, p < .0001); model estimates, standard errors (SE),
and p-values presented in the results section, Table 4,
and Figure 1 are from the PMM. For children with base-
line measures completed before the preparative regimen
and without early complications or late cGVHD, parent
proxy report of global HRQL scores were significantly
lower at 45 days (β = −8.5, SE = 2.4, p = .0003) and 3
months (β = −8.0, SE = 2.6, p = .002) than baseline. Chil-
dren with baseline measures completed during the pre-
parative regimen had baseline scores that were 12 points
lower than those with measures completed before the
regimen (β = −11.8, SE = 2.7, p < .0001), but this differ-
ence in scores diminished over time (see Table 4 for coeffi-
cients and p-values for the time*baseline timing
interaction). Parents with baseline parental emotional
functioning scores that were half a standard deviation
higher (1/2 SD = 9.5) reported their child’s global HRQL
as 3.8 points higher (SE = 0.4, p < .0001) than parents with
lower baseline emotional functioning scores. An increase
in one year of child age was associated with global HRQL
scores that were half a point lower (SE = 0.2, p = .008)
than younger children. Longer log duration of illness
was marginally associated with lower global HRQL
scores (β = −1.2, SE = 0.7, p = .07). Compared to allogen-
eic unrelated donor transplants, children with autologous
or allogeneic related donor transplants had higher globalHRQL scores over time (β = 4.2, SE = 2.2, p = .06 and
β = 4.7, SE = 2.0, p = .02, respectively). Children with
early complications experienced a marginally significant
6-point drop in global HRQL from baseline to 45 days
(β = −6.4, SE = 3.4, p = .06). The presence of late
cGVHD was associated with decreased global HRQL at
3 months (β = −21.9, SE = 9.7, p = .02) and 6 months
(β = −20.0, SE = 9.4, p = 0.03) compared to baseline.
Mean trajectories were plotted to compare global HRQL
scores by the presence of early complications or late
cGVHD (Figure 1a).
Adolescent only model results
For the “adolescent only” multivariable model, the fol-
lowing covariates and interaction terms were included
based on univariate analysis and not removed during
backwards elimination: time, baseline parental emo-
tional functioning, child age, parent gender, rater, base-
line timing, early complications, time*rater, parent
gender*rater, time*baseline timing, rater*baseline parent
emotional functioning, and time*early complications.
Similar to the “all children” model, the LRT comparing
the “adolescent only” repeated measures model to the
PMM also revealed the presence of MNAR by medical
missingness (χ2 [df = 25] = 135.8, p < .0001); model esti-
mates, SE, and p-values are from the PMM (see Table 4
and Figure 1). Among adolescents with baseline mea-
sures completed before the preparative regimen and
with no early complications, both raters did not report a
change in global HRQL over time (see estimates for time
in Table 4). When baseline measures were completed dur-
ing the preparative regimen, global HRQL scores were
reported as 15 points lower (SE = 3.4, p < .0001) compared
to those completing the measures before the preparative
Table 4 Multivariable pattern mixture models
“All Children” Model “Adolescent only” Model
β (SE) p-value β (SE) p-value
Intercept 49.7 (4.1) <.0001 90.3 (13.5) <.0001
Time
Baseline (reference)
45 days −8.5 (2.4) .0003 −3.2 (3.4) 0.35
3 months −8.0 (2.6) .002 −6.0 (3.7) 0.11
6 months −4.8 (2.6) .07 −3.5 (4.1) 0.39
12 months 2.0 (4.8) .68 −0.1 (5.1) 0.98
Baseline timing −11.8 (2.7) <.0001 −14.3 (3.4) <.0001
Time*Baseline timing
Baseline*baseline timing (reference)
45 days*baseline timing 7.5 (3.4) .03 8.6 (4.7) 0.06
3 months*baseline timing 6.8 (3.7) .07 9.7 (4.9) 0.048
6 months*baseline timing 11.5 (3.7) .002 11.7 (5.3) 0.03
12 months*baseline timing 9.6 (5.8) .10 8.8 (6.3) 0.16
Baseline parental emotional functioning for ½ SD changea 3.8 (0.4) <.0001 2.2 (0.7) 0.002
Baseline parental emotional functioning*parent rater for ½ SD changea 1.7 (0.6) 0.003
Child age −0.5 (0.2) .008 −1.7 (0.8) 0.03
Log duration of illness −1.2 (0.7) .07
Transplant Type
Autologous 4.2 (2.2) .06
Allogeneic, related 4.7 (2.0) .02
Allogeneic, unrelated (reference)
Early complicationsb −1.8 (2.7) .49 −2.0 (3.4) 0.57
Time*early complicationsb
Baseline*early complications (reference)
45 days*early complications −6.4 (3.4) .06 −10.1 (4.7) 0.03
3 months*early complications 2.3 (3.6) .52 −2.2 (4.9) 0.66
6 months*early complications 4.1 (3.8) .27 −3.3 (5.4) 0.54
12 months*early complications 0.3 (6.2) .96 −1.2 (6.3) 0.85
Late cGVHDc 7.6 (7.7) .32
Time*Late cGVHDc
Baseline*late cGVHD (reference)
45 days* late cGVHD −12.5 (9.3) .18
3 months* late cGVHD −21.9 (9.7) .02
6 months* late cGVHD −20.0 (9.4) .03
12 months* late cGVHD −14.3 (10.5) .17
Parent Female −1.5 (4.0) 0.71
Parent Rater −13.3 (4.6) 0.004
Parent female*Parent rater −6.6 (3.2) 0.04
Time*Parent rater
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Table 4 Multivariable pattern mixture models (Continued)
Baseline*parent rater (reference)
45 days*parent rater −4.5 (2.4) 0.054
3 months*parent rater −3.3 (2.4) 0.18
6 months*parent rater −1.5 (2.7) 0.57
12 months*parent rater 1.1 (2.9) 0.71
Abbreviations: SE standard error, SD standard deviation, cGVHD chronic graft versus host disease.
a A half standard deviation for the parent emotional functioning is equal to 9.5.
b Early complications refers to at least one of the following within the first 3 months: aGVHD of grade 2 or higher, intermediate or poor toxicity, or localized or
systemic infection.
c Late cGVHD refers to limited or extensive cGVHD between 6 and 12 months.
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what over time (see Table 4 for coefficients and p-values
for the time*baseline timing interaction). Adolescent
children of parents with baseline parental emotional
functioning that was a half standard deviation higher (1/
2 SD = 9.5) reported their own global HRQL as 1.9
points higher (SE = 1.0, p = .003) compared to adoles-
cent children of parents with lower emotional function-
ing scores, while their parents reported their child’s
global health an additional 1.9 points higher (SE = 1.0,Figure 1 Global HRQL means scores for “All Children” and
“Adolescent Only” based on pattern mixture models.
Abbreviations: HRQL = health-related quality of life; HSCT =
hematopoietic stem cell transplant; Adol = adolescent. Notes: Early
complications refers to at least one of the following within the first
3 months: aGVHD of grade 2 or higher, intermediate or poor
toxicity, or localized or systemic infection. Late cGVHD refers to
limited or extensive cGVHD between 6 and 12 months.p = .001) compared to parents with lower emotional
functioning scores. An increase in one year of child age
was associated with global HRQL scores that were 1.5
points lower (SE = 0.7, p = .04) compared to younger
children. At baseline, parents rated their adolescent
child’s global HRQL as 13.3 points lower than the ado-
lescent’s self-report (SE = 4.6, p = .004) and this differ-
ence increased by nearly 5 points at 45 days (β = −4.5,
SE = 2.4, p = .054). For adolescents, there was no
difference in global HRQL scores by parent gender
(β = −1.5, SE = 4.0, p = .71), but mothers rated their
adolescent child’s global HRQL 6.6 points lower than
fathers (SE = 3.2, p = .04). Among adolescents who
experienced early complications, both raters reported statis-
tically significant decreases in global HRQL at 45 days com-
pared to baseline scores (β = −10.1, SE = 4.7, p = .03).
Mean trajectories were plotted to compare global HRQL
scores by rater and the presence of early complications
(Figure 1b).
Discussion
This study has demonstrated the unidimensionality of a
7-item global HRQL scale in a sample of children
undergoing HSCT. Both parent proxy report and ado-
lescent self-report showed acceptable levels of internal
consistency reliability, little missing data, and similar item
variability. Additionally, we explored the trajectories of glo-
bal HRQL in children over the 12-month clinical course
following HSCT, which helps to establish this scale’s con-
struct validity.
This global HRQL scale, the first for use in a pediatric
population, contains items about the following areas:
physical health, mental health, family life, friendships,
self-confidence, fun, and life enjoyment. All three reports
(all children parent proxy report, adolescent only parent
proxy report, and adolescent self-report) of the global
HRQL items indicated that the child’s illness had the
most impact on their physical health as reflected by the
lowest mean item score. The Cronbach’s alpha coeffi-
cients for parent proxy report were at least 0.90, while
adolescent self-report was slightly lower (0.80). Although
the Cronbach’s alpha for the adolescent self-report is still
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tory scale development [14], other HRQL scale develop-
ment research has also shown lower levels of internal
consistency reliability in child self-report than parent
proxy report [4,19]. Principal components analysis indi-
cated that more than 60% of the variation was explained
by the single component for parent proxy report, but
only 45% of variation was explained for adolescent self-
report. Similar to lower Cronbach’s alphas in adolescent
self-report, this decreased variation explained could also
reflect differences in scale performance by parent proxy
and adolescent self-report and warrant further study.
The results of the principal components analysis,
including the scree plot and factor loadings, confirmed
the presence of a unidimensional global HRQL scale. In
contrast to multi-dimensional pediatric HRQL mea-
sures, this global HRQL scale can decrease respondent
burden, increase ease of implementation, increase
simplicity by having a single outcome, and direct future
research and evaluation. Although the unidimensional
nature of the scale may reduce the ability to discern
which areas of functioning are affected, looking at indi-
vidual item scores could provide additional information.
This measure could be completed outside of clinic to
assess changes over time or could be used prior to a
clinic visit to begin dialogue about the child’s health and
HRQL. In addition, it could serve as a screener for
either further HRQL assessment or clinical intervention.
In parallel work in adults, using the PROMIS global
scale, mapping has been done with the EuroQol 5
Dimension (EQ-5D) [11], which is a preference-based
instrument that generates a utility weight, which can be
used in cost-effectiveness or comparative effectiveness
studies.
In both the “all children” and “adolescent only” models,
higher parent emotional functioning scores were associ-
ated with higher global HRQL scores in children. When
rating the child’s HRQL, parents with lower parental emo-
tional functioning may perceive their child’s global HRQL
as lower. Although lower parental emotional functioning
could cause children and adolescents to experience lower
global HRQL themselves [15,16], the significant inter-
action between rater and baseline emotional functioning
in the “adolescent only” model indicates a larger effect on
the parent rater than the adolescent rater. Older child age
was associated with lower global HRQL scores potentially
reflecting cognitive and maturity differences in how older
children perceive their illness. In both models, the pres-
ence of early complications, such as aGVHD, toxicity, and
infection, was associated with decreased global HRQL
within the early phases of the post-HSCT course (45 days
and 3 months). Additionally, the “all children” model
showed decreased global HRQL for children with late
cGVHD within the later phases of the post-HSCT course(3 and 6 months). Given that only 7 adolescents among
the 117 included in the adolescent model had late
cGVHD, we were likely underpowered to detect any dif-
ferences in the “adolescent only” model. These decreases
in the global HRQL trajectories based on clinical out-
comes establishes construct validity of the scale. For those
who completed the measures during the preparative
regimen, global HRQL scores were lower at baseline.
These differences diminished over time in the “all
children” and “adolescent only” models.
For the “adolescent only” model, parent proxies reported
lower baseline global HRQL scores than adolescent self-
report. Inter-rater differences between parent proxies and
adolescents have several possible explanations, including in-
formation variance and criterion variance. Information vari-
ance could occur when the parent and child receive
different information about clinical events, while criterion
variance could occur when they weigh and respond to
available information differently. These rater differences
illustrate the importance of collecting pediatric HRQL data
from both the parent and the child [20]. In addition, we
found that fathers rated their adolescent child’s global
HRQL higher than mothers. Previous research has shown
that the child’s illness causes different levels of parental
distress in mothers and fathers [21], which in turn may
affect how they rate their child’s HRQL [22].
This study has several limitations. At this time, self-
reported global HRQL items were only completed by
adolescents, not from children aged five to twelve, thus
preventing us from comparing ratings in younger chil-
dren. Future testing is needed to determine how children
aged 8–12 are able to respond to the global items and sep-
arately estimate the psychometric properties within this
age group. A second limitation is that some participants
were lost to follow-up, as is common in longitudinal stud-
ies of patients with severe illnesses who are undergoing in-
tense treatment. However, by stratifying the analysis by
whether the data were missing for medical reasons using a
pattern mixture model, we mitigated the effects of data
MNAR.
Conclusions
Despite these limitations, this study presents a unidimen-
sional pediatric global HRQL scale for parent proxy report
and adolescent self-report. Our sample focused on chil-
dren undergoing HSCT, but future validation is needed in
other pediatric populations. The use of a pediatric global
HRQL scale will further facilitate the incorporation of
patient-reported and patient-centered outcomes into clin-
ical and epidemiological research and will hopefully lead
to improved outcomes in pediatric populations.
Abbreviations
aGVHD: Acute graft versus host disease; cGVHD: Chronic graft versus host
disease; CHRIs: Child Health and Ratings Inventories; HRQL: Health-related
Rodday et al. Health and Quality of Life Outcomes 2013, 11:26 Page 9 of 9
http://www.hqlo.com/content/11/1/26quality of life; HSCT: Hematopoietic stem cell transplant; HSCT-CHESS:
HSCT-Comprehensive Health Enhancement Support Study (CHESS™);
JTR: Journeys to Recovery study; MAR: Missing at random; MNAR: Missing not
at random; PCORI: Patient-Centered Outcomes Research Institute;
PMM: Pattern mixture model; PROMIS: Patient-Reported Outcome
Measurement Information System.
Competing interests
The authors have no competing interests to report.
Authors’ contributions
The studies that form the basis of the sample for this paper were developed
by SKP. Statistical analyses were devised by AMR, NT, and SKP. The first draft
of the manuscript was written by AMR and discussed with NT and SKP. All
authors contributed to the content. All authors read and approved the final
manuscript.
Acknowledgements
We would like to thank Rebecca Burns and Doris Hernandez for their
assistance in manuscript preparation. This study was supported in part by
American Cancer Society, Research Scholars Grant Number PB02-186-01-PBP
(SKP), the National Cancer Institute Grant Number R01 CA 119196 (SKP), the
National Center for Research Resources Grant Number UL1 RR025752, and
the National Center for Advancing Translational Sciences, National Institutes
of Health, Grant Number UL1 TR000073. The content is solely the
responsibility of the authors and does not necessarily represent the official
views of the NIH.
Participating institutions and site investigators in JTR and HSCT-CHESS
Studies
Central Project Staff
Tufts Medical Center, Boston, MA: Susan K. Parsons, MD, MRP, Principal
Investigator
Site Principal Investigators
Baylor College of Medicine/Texas Children’s Hospital, Houston, TX: Lynette
Harris, PhD and Robert A. Krance, MD, Principal Investigators
Children’s Hospital of Philadelphia, Philadelphia, PA: Lisa Schwartz, PhD,
Principal Investigator
Cincinnati Children’s Hospital Medical Center, Cincinnati, OH: Stella Davies,
MMBS, PhD, Principal Investigator
City of Hope, Duarte, CA: Sunita Patel, PhD, Principal Investigator; Joseph
Rosenthal, MD, Site Consultant
Dana-Farber Cancer Institute, Boston, MA: Christopher Recklitis, PhD, MPH,
JTR Principal Investigator; Eva Guinan, MD, HSCT-CHESS Principal Investigator
Fred Hutchinson Cancer Research Center, Seattle, WA: Karen L. Syrjala,
PhD, Principal Investigator; Jean Sanders, MD, Co-Principal Investigator
Medical College of Wisconsin, Milwaukee, WI: Mary Jo Kupst, PhD, Principal
Investigator; Kristin Bingen, PhD and James Casper, MD, Co-Principal
Investigators
University of Pittsburgh/Children’s Hospital of Pittsburgh, Pittsburgh, PA:
Robert B. Noll, PhD, Principal Investigator; Linda J. Ewing, PhD, RN, Co-
Principal Investigator
Author details
1The Institute for Clinical Research and Health Policy Studies, Tufts Medical
Center, Boston, MA, USA. 2Graduate Program in Clinical and Translational
Science, Sackler School of Graduate Biomedical Sciences, Tufts University,
Boston, MA, USA. 3Tufts University School of Medicine, Boston, MA, USA.
Received: 11 October 2012 Accepted: 13 February 2013
Published: 26 February 2013
References
1. Selby JV, Beal AC, Frank L: The Patient-Centered Outcomes Research
Institute (PCORI) national priorities for research and initial research
agenda. JAMA 2012, 307:1583–1584.
2. Ravens-Sieberer U, Erhart M, Wille N, Wetzel R, Nickel J, Bullinger M: Generic
health-related quality-of-life assessment in children and adolescents:
methodological considerations. PharmacoEconomics 2006, 24:1199–1220.
3. Landgraf JM, Maunsell E, Speechley KN, Bullinger M, Campbell S, Abetz L,
Ware JE: Canadian-French, German and UK versions of the Child HealthQuestionnaire: methodology and preliminary item scaling results.
Qual Life Res 1998, 7:433–445.
4. Parsons SK, Shih MC, Mayer DK, Barlow SE, Supran SE, Levy SL, Greenfield S,
Kaplan SH: Preliminary psychometric evaluation of the Child Health
Ratings Inventories (CHRIs) and Disease-Specific Impairment Inventory-
HSCT (DSII-HSCT) in parents and children. Qual Life Res 2005,
14:1613–1625.
5. Parsons SK, Shih MC, DuHamel KN, Ostroff J, Mayer DK, Austin J, Martini DR,
Williams SE, Mee L, Sexson S, et al.: Maternal perspectives on children's
health-related quality of life during the first year after pediatric
hematopoietic stem cell transplant. J Pediatr Psychol 2006, 31:1100–1115.
6. Starfield B, Bergner M, Ensminger M, Riley A, Ryan S, Green B, McGauhey P,
Skinner A, Kim S: Adolescent health status measurement: development of
the Child Health and Illness Profile. Pediatrics 1993, 91:430–435.
7. Varni JW, Seid M, Rode CA: The PedsQL: measurement model for the
pediatric quality of life inventory. Med Care 1999, 37:126–139.
8. Ravens-Sieberer U, Gosch A, Rajmil L, Erhart M, Bruil J, Duer W, Auquier P,
Power M, Abel T, Czemy L, et al: KIDSCREEN-52 quality-of-life measure for
children and adolescents. Expert Rev Pharmacoecon Outcomes Res 2005,
5:353–364.
9. Irwin DE, Gross HE, Stucky BD, Thissen D, Dewitt EM, Lai JS, Amtmann D,
Khastou L, Varni JW, DeWalt DA: Development of six PROMIS pediatrics
proxy-report item banks. Health Qual Life Outcomes 2012, 10:22.
10. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey
(SF-36). I. Conceptual framework and item selection. Med Care 1992,
30:473–483.
11. Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D: Development of
physical and mental health summary scores from the patient-reported
outcomes measurement information system (PROMIS) global items.
Qual Life Res 2009, 18:873–880.
12. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA,
Thomas ED: Regimen-related toxicity in patients undergoing bone
marrow transplantation. J Clin Oncol 1988, 6:1562–1568.
13. Cronbach LJ: Coefficient alpha and the internal structure of tests.
Psychometrika 1951, 16:297–334.
14. Nunnally J, Bernstein I: Psychometric Theory. New York, NY: McGraw-Hill, Inc.;
1994.
15. Jobe-Shields L, Alderfer M, Barrera M, Vannatta K, Currier J, Phipps S:
Parental depression and family environment predict distress in children
prior to stem-cell transplantation. J Dev Behav Pediatr 2009, 30:140–146.
16. Barrera M, Boyd-Pringle LA, Sumbler K, Saunders F: Quality of life and
behavioral adjustment after pediatric bone marrow transplantation.
Bone Marrow Transplant 2000, 26:427–435.
17. Parsons SK, Shih MC, Ratichek S, Recklitis CJ, Chang G, for the Journeys to
Recovery Study: Establishing the Baseline in Longitudinal Evaluation of Health-
Related Quality of Life (HRQL): The Pediatric Hematopoietic Stem Cell
Transplantation (HSCT) Example. National Cancer Institute, September:
Presentation at the Patient-Reported Outcomes Assessment in Cancer Trials;
2006:2006.
18. Hedeker D, Gibbons R: Application of random-effects pattern-mixture
models for missing data in longitudinal studies. Psychol Methods 1997,
2:64–78.
19. Varni JW, Seid M, Kurtin PS: PedsQL 4.0: reliability and validity of the
Pediatric Quality of Life Inventory version 4.0 generic core scales in
healthy and patient populations. Med Care 2001, 39:800–812.
20. Parsons SK, Fairclough DL, Wang J, Hinds PS: Comparing longitudinal
assessments of quality of life by patient and parent in newly diagnosed
children with cancer: the value of both raters' perspectives. Qual Life Res
2012, 21:915–923. Epub ahead of print 2011 Aug 6.
21. Barrera M, Atenafu E, Doyle J, Berlin-Romalis D, Hancock K:
Differences in mothers' and fathers' health-related quality of life
after pediatric SCT: a longitudinal study. Bone Marrow Transplant
2012, 47:934–939.
22. Davis E, Davies B, Waters E, Priest N: The relationship between proxy
reported health-related quality of life and parental distress: gender
differences. Child Care Health Dev 2008, 34:830–837.
doi:10.1186/1477-7525-11-26
Cite this article as: Rodday et al.: Measuring global health-related quality
of life in children undergoing hematopoietic stem cell transplant: a
longitudinal study. Health and Quality of Life Outcomes 2013 11:26.
